Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ex vivo-expanded allogeneic NK cells after Cy/Flu conditioning in elderly AML
NL-OMON38045Phase 1Not yet recruiting
- Sponsor
- Radboud University Medical Center
- Start
- May 2011
- Countries
- 1
01
Overview
Phase 1, open-label trial in acute myeloid leukemia (AML) (4 cohorts), sponsored by Radboud University Medical Center. Primary endpoints: Safety and Toxicity. Planned start May 2011; status: not yet recruiting.
02
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NL-OMON38045.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON38045.